Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

Kajal Chaudhry, Ashley Geiger, Ehsan Dowlati, Haili Lang, Danielle Sohai, Eugene Hwang, Christopher A. Lazarski, Eric Yvon, Matthias Holdhoff, R. Brad Jones,

Molecular Therapy — Methods & Clinical Development · 2022 · 43 citations · 46 references

DOIFull text

Open access

Concepts

Abstract

. However, transforming growth factor (TGF)-β within the tumor microenvironment has devastating effects on the cytolytic activity of both unmodified and CAR-transduced NK cells. To overcome this potent immune suppression, we demonstrated that co-transducing NK cells with a B7H3 CAR and a TGF-β dominant negative receptor (DNR) preserves cytolytic function in the presence of exogenous TGF-β. This study demonstrates that a novel DNR and CAR co-expression strategy may be a promising therapeutic for recalcitrant CNS tumors like GBM.

References

46